Agreement of Different Drug-Drug Interaction Checkers for Proton Pump Inhibitors.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 7, p. e2419851, doi. 10.1001/jamanetworkopen.2024.19851
- By:
- Publication type:
- Article
Works matching Proton pump inhibitors (drug interactions)
Results: 81
1
2
Pharmacokinetic drug interaction profiles of proton pump inhibitors.
- Published in:
- 2006
- By:
- Publication type:
- journal article
3
A comprehensive review on potential drug–drug interactions of proton pump inhibitors with antidiabetic drugs metformin and DPP‐4 inhibitors.
- Published in:
- Cell Biochemistry & Function, 2024, v. 42, n. 2, p. 1, doi. 10.1002/cbf.3967
- By:
- Publication type:
- Article
4
In vitro and in vivo evaluation of drug-drug interaction between dabigatran and proton pump inhibitors.
- Published in:
- Fundamental & Clinical Pharmacology, 2015, v. 29, n. 6, p. 604, doi. 10.1111/fcp.12154
- By:
- Publication type:
- Article
5
Effect of the Clopidogrel-Proton Pump Inhibitor Drug Interaction on Adverse Cardiovascular Events in Patients with Acute Coronary Syndrome.
- Published in:
- Pharmacotherapy, 2012, v. 32, n. 9, p. 809, doi. 10.1002/j.1875-9114.2012.01112.x
- By:
- Publication type:
- Article
6
Suspicion of Drug-Drug Interaction between High-Dose Methotrexate and Proton Pump Inhibitors: A Case Report - Should the Practice Be Changed?
- Published in:
- Chemotherapy (0009-3157), 2011, v. 57, n. 3, p. 225, doi. 10.1159/000327372
- By:
- Publication type:
- Article
7
Evaluation of Potential Drug Interactions with Proton Pump Inhibitors: A Retrospective Study.
- Published in:
- Journal of Literature Pharmacy Sciences, 2023, v. 12, n. 1, p. 1, doi. 10.5336/pharmsci.2022-94331
- By:
- Publication type:
- Article
8
Navigating Drug Interactions with Proton Pump Inhibitors.
- Published in:
- 2024
- By:
- Publication type:
- Opinion
9
Pancytopenia Due to Possible Drug–Drug Interactions Between Low-Dose Methotrexate and Proton Pump Inhibitors.
- Published in:
- Drug, Healthcare & Patient Safety, 2022, v. 14, p. 75, doi. 10.2147/DHPS.S350194
- By:
- Publication type:
- Article
10
Confounding factors for variation of clozapine plasma levels: drug interactions with proton pump inhibitor or infectious etiologies?
- Published in:
- 2011
- By:
- Publication type:
- Case Study
11
Pharmacokinetic drug interaction profiles of proton pump inhibitors: an update.
- Published in:
- 2014
- By:
- Publication type:
- journal article
12
Antiplatelet drug interactions with proton pump inhibitors.
- Published in:
- Expert Opinion on Drug Metabolism & Toxicology, 2014, v. 10, n. 2, p. 175, doi. 10.1517/17425255.2014.856883
- By:
- Publication type:
- Article
13
Adverse drug reactions due to drug–drug interactions with proton pump inhibitors: assessment of systematic reviews with AMSTAR method.
- Published in:
- Expert Opinion on Drug Safety, 2016, v. 15, n. 2, p. 223, doi. 10.1517/14740338.2016.1128413
- By:
- Publication type:
- Article
14
An update on oral antiplatelet drug interactions with proton pump inhibitors: what are the risks?
- Published in:
- Expert Opinion on Drug Metabolism & Toxicology, 2024, v. 20, n. 8, p. 749, doi. 10.1080/17425255.2024.2378888
- By:
- Publication type:
- Article
15
An update on drug–drug interactions associated with proton pump inhibitors.
- Published in:
- Expert Opinion on Drug Metabolism & Toxicology, 2022, v. 18, n. 5, p. 337, doi. 10.1080/17425255.2022.2098107
- By:
- Publication type:
- Article
16
Drug Interactions Produced by Proton Pump Inhibitors: Not Simply a pH Effect.
- Published in:
- Clinical Pharmacology & Therapeutics, 2013, v. 93, n. 2, p. 150, doi. 10.1038/clpt.2012.182
- By:
- Publication type:
- Article
17
Response to 'Drug Interactions Produced by Proton Pump Inhibitors: Not Simply a pH Effect'.
- Published in:
- Clinical Pharmacology & Therapeutics, 2013, v. 93, n. 2, p. 151, doi. 10.1038/clpt.2012.206
- By:
- Publication type:
- Article
18
Clinical Implications of the Nelfinavir-Proton Pump Inhibitor Drug Interaction in Patients with Human Immunodeficiency Virus.
- Published in:
- Pharmacotherapy, 2011, v. 31, n. 3, p. 253, doi. 10.1592/phco.31.3.253
- By:
- Publication type:
- Article
19
Drug Interaction Between Clopidogrel and Proton Pump Inhibitors.
- Published in:
- Pharmacotherapy, 2010, v. 30, n. 3, p. 275, doi. 10.1592/phco.30.3.275
- By:
- Publication type:
- Article
20
Phase I study to evaluate of the gastric pH-dependent drug interaction between famitinib and the proton pump inhibitor omeprazole in healthy subjects.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 6, p. 1274, doi. 10.1007/s10637-022-01299-3
- By:
- Publication type:
- Article
21
Indications, appropriateness and drug interactions of proton pump inhibitors prescribed at hospital discharge in older medical patients.
- Published in:
- Geriatrics & Gerontology International, 2017, v. 17, n. 8, p. 1238, doi. 10.1111/ggi.13043
- By:
- Publication type:
- Article
22
Increase in cetuximab-induced skin rash and hypomagnesemia in patients receiving concomitant treatment with proton pump inhibitors (PPIs): a possible drug interaction?
- Published in:
- 2019
- By:
- Publication type:
- journal article
23
Assessment of drug-drug interaction potential between ceritinib and proton pump inhibitors in healthy subjects and in patients with ALK-positive non-small cell lung cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
24
Drug-Drug Interaction Profiles of Proton Pump Inhibitors.
- Published in:
- Clinical Pharmacokinetics, 2010, v. 49, n. 8, p. 509, doi. 10.2165/11531320-000000000-00000
- By:
- Publication type:
- Article
25
Comment: Drug-Drug Interaction Between Clopidogrel and the Proton Pump Inhibitors.
- Published in:
- Annals of Pharmacotherapy, 2010, v. 44, n. 1, p. 225, doi. 10.1345/aph.1M051a
- Publication type:
- Article
26
Drug-Drug Interaction Between Clopidogrel and the Proton Pump Inhibitors.
- Published in:
- Annals of Pharmacotherapy, 2009, v. 43, n. 7/8, p. 1266, doi. 10.1345/aph.1M051
- Publication type:
- Article
27
Drug Regulatory Agencies' Role in the Interaction Between Clopidogrel and Proton Pump Inhibitors.
- Published in:
- 2011
- By:
- Publication type:
- Letter
28
Adverse reactions of immune checkpoint inhibitors combined with Proton pump inhibitors: a pharmacovigilance analysis of drug-drug interactions.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12947-7
- By:
- Publication type:
- Article
29
Accumulating Evidence for a Drug-Interaction Between Methotrexate and Proton Pump Inhibitors.
- Published in:
- Oncologist, 2012, v. 17, n. 4, p. 550, doi. 10.1634/theoncologist.2011-0431
- By:
- Publication type:
- Article
30
Clopidogrel and Proton Pump Inhibitors: Is There a Significant Drug-Drug Interaction?
- Published in:
- Canadian Journal of Cardiovascular Nursing, 2011, v. 21, n. 4, p. 27
- By:
- Publication type:
- Article
31
The drug-drug interaction between proton pump inhibitors and clopidogrel.
- Published in:
- 2009
- By:
- Publication type:
- journal article
32
A population-based study of the drug interaction between proton pump inhibitors and clopidogrel.
- Published in:
- Canadian Medical Association Journal (CMAJ), 2009, v. 180, n. 7, p. 713, doi. 10.1503/cmaj.082001
- By:
- Publication type:
- Article
33
The drug--drug interaction between proton pump inhibitors and clopidogrel.
- Published in:
- 2009
- By:
- Publication type:
- Opinion
34
The potential drug-drug interaction between proton pump inhibitors and warfarin.
- Published in:
- 2015
- By:
- Publication type:
- Other
35
Changes in gastric pH and in pharmacokinetics of ulipristal acetate -- a drug-drug interaction study using the proton pump inhibitor esomeprazole.
- Published in:
- International Journal of Clinical Pharmacology & Therapeutics, 2013, v. 51, n. 1, p. 26, doi. 10.5414/CP201789
- By:
- Publication type:
- Article
36
Formulary management of proton pump inhibitors.
- Published in:
- 1999
- By:
- Publication type:
- journal article
37
Protracted Episode of Reduced Consciousness Following Co-Medication with Omeprazole and Clorazepate.
- Published in:
- Clinical Drug Investigation, 2000, v. 19, n. 4, p. 307, doi. 10.2165/00044011-200019040-00008
- By:
- Publication type:
- Article
38
Lack of Pharmacokinetic and Pharmacodynamic Interaction Between Pantoprazole and Glibenclamide in Humans.
- Published in:
- Clinical Drug Investigation, 1998, v. 15, n. 3, p. 253, doi. 10.2165/00044011-199815030-00010
- By:
- Publication type:
- Article
39
A summary of Food and Drug Administration-reported adverse events and drug interactions occurring during therapy with omeprazole, lansoprazole and pantoprazole.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2003, v. 17, n. 8, p. 1015, doi. 10.1046/j.1365-2036.2003.01550.x
- By:
- Publication type:
- Article
40
Managing potential drug-drug interactions between gastric acid-reducing agents and antiretroviral therapy: experience from a large HIV-positive cohort.
- Published in:
- 2016
- By:
- Publication type:
- journal article
41
Applications, Challenges, and Outlook for PBPK Modeling and Simulation: A Regulatory, Industrial and Academic Perspective.
- Published in:
- Pharmaceutical Research, 2022, v. 39, n. 8, p. 1701, doi. 10.1007/s11095-022-03274-2
- By:
- Publication type:
- Article
42
Clopidogrel Resistance in Ischemic Stroke Patients.
- Published in:
- Annals of Indian Academy of Neurology, 2024, v. 27, n. 5, p. 493, doi. 10.4103/aian.aian_79_24
- By:
- Publication type:
- Article
43
Metformin as an Adjunctive Therapy for Pancreatic Cancer: A Review of the Literature on Its Potential Therapeutic Use.
- Published in:
- 2018
- By:
- Publication type:
- journal article
44
Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoprotein.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2001, v. 364, n. 6, p. 551, doi. 10.1007/s00210-001-0489-7
- By:
- Publication type:
- Article
45
The Effect of Concomitant Proton Pump Inhibitor and Cabozantinib on the Outcomes of Patients with Metastatic Renal Cell Carcinoma.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. 389, doi. 10.1002/onco.13711
- By:
- Publication type:
- Article
46
Gastroesophageal Reflux in Children: Pathogenesis, Prevalence, Diagnosis, and Role of Proton Pump Inhibitors in Treatment.
- Published in:
- Pediatric Drugs, 2002, v. 4, n. 10, p. 673, doi. 10.2165/00148581-200204100-00004
- By:
- Publication type:
- Article
47
Enzalutamide: Understanding and Managing Drug Interactions to Improve Patient Safety and Drug Efficacy.
- Published in:
- Drug Safety, 2024, v. 47, n. 7, p. 617, doi. 10.1007/s40264-024-01415-7
- By:
- Publication type:
- Article
48
Severe Impact of Omeprazole Timing on pH‐Sensitive Dasatinib Absorption: Unveiling Substantial Drug–Drug Interaction.
- Published in:
- Journal of Clinical Pharmacology, 2025, v. 65, n. 5, p. 588, doi. 10.1002/jcph.6173
- By:
- Publication type:
- Article
49
Evaluation of the effect of food and gastric pH on the single-dose pharmacokinetics of cabozantinib in healthy adult subjects.
- Published in:
- Journal of Clinical Pharmacology, 2015, v. 55, n. 11, p. 1293, doi. 10.1002/jcph.526
- By:
- Publication type:
- Article
50
Clopidogrel, CYP2C19, and a Black Box.
- Published in:
- Journal of Clinical Pharmacology, 2013, v. 53, n. 3, p. 241, doi. 10.1002/jcph.17
- By:
- Publication type:
- Article